Market Overview

Research and Markets: Global Cystic Fibrosis Epidemiology and Patient Flow Analysis - 2012


Research and Markets ( has announced the addition of the "Global Cystic Fibrosis Epidemiology and Patient Flow Analysis - 2012" report to their offering.

This report provides insights into Cystic Fibrosis epidemiology, Cystic Fibrosis diagnosed patients, and Cystic Fibrosis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Cystic Fibrosis derived from epidemiological analysis, percentage of patients diagnosed with Cystic Fibrosis, and percentage of patients treated with Cystic Fibrosis therapy.

The study helps executives estimate Cystic Fibrosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Cystic Fibrosis prevalence, Cystic Fibrosis diagnosis rate, and Cystic Fibrosis treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:

- Cystic Fibrosis: Disease Definition

- Cystic Fibrosis Patient Flow

- Cystic Fibrosis Prevalence

- Cystic Fibrosis Diagnosed Patients

- Cystic Fibrosis Treated Patients

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

View Comments and Join the Discussion!